Research studies have shown that GLP-1 RA appears to prevent hospitalizations for new onset heart failure and reduce symptoms in heart failure with preserved ejection fraction, thus, making them a strategic tool in management of heart failure [13]. This evidence concerns the gene GCG and heart failure.